Shanghai INT Medical Instruments (HKG:1501) recorded a rise in attributable profit in 2025 to 218.8 million yuan from 191.9 million yuan a year prior, according to a March 27 Hong Kong bourse filing.
Shares of the medical device maker were up nearly 6% in Monday afternoon trading.
Earnings per share rose to 1.26 yuan from 1.10 yuan in the previous fiscal year.
Revenue increased 25% to 1.07 billion yuan from 852 million yuan in the year-ago period, mainly due to a higher number of new customers.
The company recommended a final dividend of 0.23 yuan per share for the year, payable on or around June 30 to shareholders of record on June 10.
Comments